Article

Fear Less

A cancer diagnosis brings with it a world of fears, but living with advanced/terminal cancer puts the other fears into perspective.

The heart may freeze or it can burn The pain will ease if I can learn

There is no future There is no past Thank God this moment's not the last

There's only us There's only this Forget regret — or life is yours to miss. No other road No other way No day but today

- Lyrics from"No Day But Today" (from the musical "Rent")

Scan time is looming large on the horizon, so in addition to trying to take my own advice (see "10 Tips for Coping with Scanxiety"), I have been ruminating on the meaning of fear.

Why is scan time so scary? First, there are lots of little fears that flit around my mind, such as...

  • I'm scared the IV will hurt.
  • I'm scared the contrast drink will make me throw up.
  • I'm scared that I might have some weird allergic reaction to the injected contrast dye.
  • I'm scared that when they inject the dye and it makes you feel like you wet your pants, that I might actually wet my pants.
  • I'm scared that I might breathe in when I'm supposed to hold my breath, or breathe out when I'm supposed to breathe in.
  • I'm scared that I might reach to scratch my nose when I am supposed to be holding still in the scanner.

But, of course, there is the one fear, the real fear, the one really big fear: The scan might show that my medicine has stopped working.

I used to do partner acro, and my instructor described me as "fearless." While it was a nice compliment, it was completely inaccurate. I certainly was not without fear, it was just that my desire to learn and push myself was much greater than my fear of getting hurt. The thrill of flying was much stronger than the fear of falling.

Now, my fears have shifted. Everything boils down to the one big fear that the medicine has stopped controlling my cancer. If that happened, it would mean pursuing new treatment and facing new side effects. It would mean that one of my limited options is used up. It would mean facing the fear that my time on earth is much, much shorter than I would like it to be and that this disease will take me away from the life and the people I love so much.

I was never "fearless," but now I do have less fear. I have less fear about little things, less fear about speaking my mind, less fear about taking chances and less fear about what other people might think of me. I have one giant fear that trumps everything else and that puts it all in perspective.

My drive to get everything I can out of this life is much greater than all the little fears. We only get this one life (I think), so it only makes sense to grab on tight and get all the living you can out of it.

Tori Tomalia is many things: a mom, a wife, a theatre artist, a mediocre cook, a Buffy fan, a stinky cheese aficionado. She is also, unfortunately, a repeat visitor to CancerLand. Stay tuned for her continued adventures.

Facebook: facebook.com/lungcancerblogger

Twitter: twitter.com/lil_lytnin

Blog: "A Lil Lytnin' Strikes Lung Cancer" lil-lytnin.blogspot.com

Related Videos
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Anna Arthur is the Director of the Medical Nutrition Science Program, as well as a tenure-track Assistant Professor in the Department of Dietetics and Nutrition at the University of Kansas Medical Center.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Kate, Princess of Wales, ‘Got So Attached’ to Her Port During Cancer Treatment
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.
Dr. Michael Bogenschutz
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Stephanie Alice Baker
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.